March 27, 2017
The latest round of Medicare’s Competitive Bidding Program for diabetes testing supplies reduced beneficiary choice and access to commonly used diabetes testing supplies, adversely affecting patient outcomes, according to a survey released by the American Association of Diabetes Educators.
“We’re still deeply concerned that the competitive bidding program is harming persons with diabetes by limiting their access to diabetes testing supplies, as prescribed by their treating providers,” Kurt Anderson, AADE Director of Federal and State Advocacy, told Endocrine Today. “It’s difficult to overstate how important self-monitoring is, especially if you’re beginning diabetes self-management training. You have to have consistency of supplies; you have to be familiar with the different devices that you have. Any break or rupture in that continuity is very difficult on patients.”